Ropes & Gray, Cleary Gottlieb Steen & Hamilton and Mintz, Levin are advising TPG on the transaction. TPG (NASDAQ: TPG), a leading global alternative asset management...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Novavax Inc. in the transaction. Novavax Inc.(Nasdaq: NVAX) announced it has entered into a co-exclusive licensing agreement with French pharmaceutical company Sanofi...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Eversource Energy in the transaction. Eversource Energy (NYSE: ES) (“Eversource”) announced its definitive agreement to sell its 50 percent ownership stake in the 924-megawatt Sunrise Wind project...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised New Mountain Capital on the deal. New Mountain Capital announced its acquisition of ALKU, a provider of specialized contingent staffing and consulting services....
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, announced the closing a transaction with Bayer for a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Ginkgo Bioworks on the deal. Ginkgo Bioworks, a horizontal platform for cell programming, signed an agreement with Bayer to expand Ginkgo’s platform capabilities...
You must be a Standard 1 Year member to access this content.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
You must be a Standard 1 Year member to access this content.
